Champoux Jennifer

CIK 00020252331 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0002025233

Recent Transactions

18 trades

Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-23$3.98/sh+2,175→ 64,546 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-23$20.00/sh−2,175→ 62,371 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-06-23−2,175→ 31,298 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-17$3.98/sh+2,176→ 64,547 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-06-17$19.00/sh−2,176→ 62,371 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-06-17−2,176→ 33,473 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-05-27$3.98/sh+2,175→ 64,546 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-05-27$20.00/sh−2,175→ 62,371 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-05-27−2,175→ 35,649 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-05-22$3.98/sh+2,176→ 64,547 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-05-22$19.00/sh−2,176→ 62,371 total
Exercise/Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-05-22−2,176→ 37,824 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-05$15.17/sh−2,629→ 62,371 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-02+35,000→ 65,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-01-02+158,000→ 158,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2025-01-02+30,000→ 30,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-01-02+135,000→ 135,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-06-03+40,000→ 40,000 total

Companies

Monte Rosa Therapeutics, Inc.
Chief Operating Officer
$GLUE

Recent Filings

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118

View on SEC.gov